Clinical Trial Update: Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the cardioprotective effect of L-carnitine and silymarin in patients receiving anthracycline chemotherapy for breast cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• L-carnitine (L-carnitine)
• Silymarin (silymarin)

Snippet

Sponsor: Horus University | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED